Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Outcomes Of Allogeneic Blood Or Marrow Transplantation (AlloBMT) In Multiple Myeloma With Post-Transplantation Cyclophosphamide (PTCy)

Nilanjan Ghosh, MD, PhD, Xiaobu Ye, MD, MS, Javier Bolaños-Meade, MD, Ephraim J. Fuchs, Leo Luznik, Jennifer A. Kanakry, Robert A. Brodsky, MD, Mark Levis, MD, PhD, Lode J. Swinnen, Douglas Gladstone, MD, Yvette L. Kasamon, Richard F. Ambinder, Richard J. Jones, William Matsui, MD, Ivan M. Borrello, MD, Carol Ann Huff, M.D.

Blood (2013) 122 (21): 3407.

https://doi.org/10.1182/blood.V122.21.3407.3407

Published: 2013

Journal Articles

Administration Of An Oral PDE5 Inhibitor, Tadalafil In Conjunction With a Lenalidomide Containing Regimen In Patients With Multiple Myeloma

Nilanjan Ghosh, MD, PhD, Lakshmi Rudraraju, MS, Xiaobu Ye, MD, MS, Kimberly Noonan, PhD, MPH, Carol Ann Huff, M.D., Ivan M. Borrello, MD

Blood (2013) 122 (21): 1959.

https://doi.org/10.1182/blood.V122.21.1959.1959

Published: 2013

Journal Articles

The Analgesic Effect of Magnetic Acupressure During Bone Marrow Aspiration and Biopsy Procedure in Cancer Patients: A Randomized, Blinded, Placebo Controlled Trial.

Ting Bao, MD, Xiaobu Ye, MD, MS, Janice Skinner, CRNP, Bing Cao, Joy Fisher, MA, CCRP, Suzanne Nesbit, Pharm.D., BCPS, Stuart A. Grossman, MD

Blood (2009) 114 (22): 71.

https://doi.org/10.1182/blood.V114.22.71.71

Published: 2009

Journal Articles

Bortezomib and Thalidomide, a Steroid Free Regimen in Newly Diagnosed Patients with Multiple Myeloma.

Nilanjan Ghosh, Anna Ferguson, RN, Xiaobu Ye, Carol A. Huff, MD, Ivan M. Borrello, MD

Blood (2009) 114 (22): 2867.

https://doi.org/10.1182/blood.V114.22.2867.2867

Published: 2009

Journal Articles

Clinical and Laboratory Risk Factors for Venous Thromboembolism in Patients with High-Grade Gliomas: Results of a Prospective Study of 107 Newly-Diagnosed Patients.

Michael B. Streiff, MD, Xiaobu Ye, MD, Serena Desideri, MD, Thomas Kickler, MD, Jayesh Jani, Stuart Grossman, MD

Blood (2008) 112 (11): 1828.

https://doi.org/10.1182/blood.V112.11.1828.1828

Published: 2008

Journal Articles

Low Incidence of CMV Reactivation and Infectious Morbidity and Mortality after Nonmyeloablative Haploidentical Bone Marrow Transplantation Incorporating Post-Transplantation Cyclophosphamide.

Heather J. Symons, MD, Xiaobu Ye, MD, Leo Luznik, MD, Michele Phelps, Angelita Crawford, M. Yair Levy, MD, Richard J. Jones, MD, Ephraim J. Fuchs, MD

Blood (2005) 106 (11): 3245.

https://doi.org/10.1182/blood.V106.11.3245.3245

Published: 2005

NARROW

Outcomes Of Allogeneic Blood Or Marrow Transplantation (AlloBMT) In Multiple Myeloma With Post-Transplantation Cyclophosphamide (PTCy)

Administration Of An Oral PDE5 Inhibitor, Tadalafil In Conjunction With a Lenalidomide Containing Regimen In Patients With Multiple Myeloma

The Analgesic Effect of Magnetic Acupressure During Bone Marrow Aspiration and Biopsy Procedure in Cancer Patients: A Randomized, Blinded, Placebo Controlled Trial.

Bortezomib and Thalidomide, a Steroid Free Regimen in Newly Diagnosed Patients with Multiple Myeloma.

Clinical and Laboratory Risk Factors for Venous Thromboembolism in Patients with High-Grade Gliomas: Results of a Prospective Study of 107 Newly-Diagnosed Patients.

Low Incidence of CMV Reactivation and Infectious Morbidity and Mortality after Nonmyeloablative Haploidentical Bone Marrow Transplantation Incorporating Post-Transplantation Cyclophosphamide.

Email alerts

ASH Publications

American Society of Hematology

Outcomes Of Allogeneic Blood Or Marrow Transplantation (AlloBMT) In Multiple Myeloma With Post-Transplantation Cyclophosphamide (PTCy)

Administration Of An Oral PDE5 Inhibitor, Tadalafil In Conjunction With a Lenalidomide Containing Regimen In Patients With Multiple Myeloma

The Analgesic Effect of Magnetic Acupressure During Bone Marrow Aspiration and Biopsy Procedure in Cancer Patients: A Randomized, Blinded, Placebo Controlled Trial.

Bortezomib and Thalidomide, a Steroid Free Regimen in Newly Diagnosed Patients with Multiple Myeloma.

Clinical and Laboratory Risk Factors for Venous Thromboembolism in Patients with High-Grade Gliomas: Results of a Prospective Study of 107 Newly-Diagnosed Patients.

Low Incidence of CMV Reactivation and Infectious Morbidity and Mortality after Nonmyeloablative Haploidentical Bone Marrow Transplantation Incorporating Post-Transplantation Cyclophosphamide.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only